Trial site
Centro de Investigaciones Clinicas del Litoral
- 17running trials
- 5closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Obesity11 trials
- Heart failure9 trials
- Type 2 diabetes5 trials
- Stroke4 trials
- Atrial fibrillation2 trials
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- High blood pressure2 trials
- Amyloidosis1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 318 trials
- Phase 24 trials
- Status
- Recruiting8 trials
- Not yet recruiting5 trials
- Active, not recruiting4 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company10 trials
- Amgen3 trials
- Boehringer Ingelheim3 trials
- Novo Nordisk A/S3 trials
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure6 recruiting
- Obesity6 recruiting
- Type 2 diabetes3 recruiting
- High blood pressure2 recruiting
- Stroke2 recruiting
- Amyloidosis1 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
Closed trials
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026